Literature DB >> 322700

Treatment of TRIC infection of the eye with rifampicin or chloramphenicol.

S Darougar, M Viswalingam, J D Treharne, J R Kinnison, B R Jones.   

Abstract

An open trial was carried out on 63 patients in London to assess the efficacy of 1% rifampicin eye ointment in comparison with 1% chloramphenicol eye ointment in the treatment of sexually transmitted TRIC infection of the eye. Patients included were selected on the basis of positive cultures for Chlamydia trachomatis. Three weeks' treatment with rifampicin eye ointment used 3 times daily was not sufficient to cure the disease, but a 6 or 7 week course gave 90% clinical and microbiological cure rate. Treatment with chloramphenicol eye ointment 3 times daily for 4 to 6 weeks failed to cure the disease.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 322700      PMCID: PMC1042934          DOI: 10.1136/bjo.61.4.255

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  5 in total

1.  Blinding and non-blinding trachoma: assessment of intensity of upper tarsal inflammatory disease and disabling lesions.

Authors:  C R Dawson; B R Jones; S Darougar
Journal:  Bull World Health Organ       Date:  1975       Impact factor: 9.408

2.  Rifampicin, an antitrachoma antibiotic.

Authors:  Y Becker
Journal:  Isr J Med Sci       Date:  1972 Aug-Sep

3.  Conjunctival swabbing for the isolation of TRIC agent (Chlamydia).

Authors:  S Darougar; B R Jones
Journal:  Br J Ophthalmol       Date:  1971-09       Impact factor: 4.638

4.  Anti-trachoma activity of rifampicin and rifamycin SV derivatives.

Authors:  Y Becker; Y Asher; N Himmel; Z Zakay-Rones
Journal:  Nature       Date:  1970-01-31       Impact factor: 49.962

5.  Topical tetracycline and rifampicin therapy of endemic trachoma in Tunisia.

Authors:  C R Dawson; I Hoshiwara; T Daghfous; M Messadi; D W Vastine; J Schachter
Journal:  Am J Ophthalmol       Date:  1975-05       Impact factor: 5.258

  5 in total
  11 in total

1.  Unusual chlamydial infection in a human renal allograft recipient.

Authors:  P D Griffiths; R I Lechler; J D Treharne
Journal:  Br Med J       Date:  1978-11-04

2.  Rapid serological test for diagnosis of chlamydial ocular infections.

Authors:  S Darougar; J D Treharne; D Minassian; H El-Sheikh; R J Dines; B R Jones
Journal:  Br J Ophthalmol       Date:  1978-08       Impact factor: 4.638

3.  Oral doxycycline in the treatment of adult chlamydial ophthalmia.

Authors:  N D Viswalingam; S Darougar; P Yearsley
Journal:  Br J Ophthalmol       Date:  1986-04       Impact factor: 4.638

4.  Marginal corneal abscess associated with adult chlamydial ophthalmia.

Authors:  S Darougar; N D Viswalingam
Journal:  Br J Ophthalmol       Date:  1988-10       Impact factor: 4.638

5.  Topical therapy of hyperendemic trachoma with rifampicin, oxytetracycline, or spiramycin eye ointments.

Authors:  S Darougar; B R Jones; N Viswalingam; J Allami; D Minassian; M A Farahmandian; A Houshmand
Journal:  Br J Ophthalmol       Date:  1980-01       Impact factor: 4.638

6.  Treatment of nongonococcal urethritis with rifampicin as a means of defining the role of Ureaplasma urealyticum.

Authors:  E D Coufalik; D Taylor-Robinson; G W Csonka
Journal:  Br J Vener Dis       Date:  1979-02

7.  Clinical and epidemiological features of adenovirus keratoconjunctivitis in London.

Authors:  S Darougar; R H Grey; U Thaker; D A McSwiggan
Journal:  Br J Ophthalmol       Date:  1983-01       Impact factor: 4.638

8.  Acute follicular conjunctivitis and keratoconjunctivitis due to herpes simplex virus in London.

Authors:  S Darougar; P A Hunter; M Viswalingam; J A Gibson; B R Jones
Journal:  Br J Ophthalmol       Date:  1978-12       Impact factor: 4.638

9.  A double-blind comparison of topical therapy of chlamydial ocular infection (TRIC infection) with rifampicin or chlortetracycline.

Authors:  S Darougar; N Viswalingam; H El-Sheikh; P A Hunter; P Yearsley
Journal:  Br J Ophthalmol       Date:  1981-08       Impact factor: 4.638

10.  Epidemiological and clinical features of primary herpes simplex virus ocular infection.

Authors:  S Darougar; M S Wishart; N D Viswalingam
Journal:  Br J Ophthalmol       Date:  1985-01       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.